🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Serum creatinine kinase (CK) level varies with age, gender, race and physic...
Status
Completed
Location
CHRU Nancy
Start Date
2021-05-01
Trial ID
NCT04838509
Treatments Being Tested
Study Aim is creation of the Hospital Register of patients with heart failu...
Status
Active Not Recruiting
Location
Moscow State Clinical Hospital named after V.V. Veresaev
Start Date
2023-09-01
Trial ID
NCT06114498
Treatments Being Tested
Double-blind randomized placebo-controlled clinical trial with two parallel...
Status
Recruiting
Location
Elisabet Palomera
Start Date
2025-06-10
Trial ID
NCT06925880
Treatments Being Tested
There is compelling evidence that some dietary supplements consumed by the ...
Status
Completed
Location
Loughborough University, School of Sport and Exercise Sciences
Start Date
2006-03
Trial ID
NCT00682123
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
Endothelium is considered a real member, so it is contributing to determine...
Status
Completed
Location
Toulouse, Rangueil Hospital
Start Date
2007-12-11
Trial ID
NCT02779127
Creatine (CR) supplementation is commonly used by athletes. However, its ef...
Status
Completed
Location
University of Sao Paulo
Start Date
2004-01
Trial ID
NCT00465140
Treatments Being Tested
The study will consist of a total of four visits. On the day of the first v...
Status
Completed
Location
Bitlis Eren Üniversites
Start Date
2026-01-05
Trial ID
NCT07735988
Treatments Being Tested
In 2020, Dubois and Esculier proposed a paradigm shift in the acute managem...
Status
Not Yet Recruiting
Location
The University of Texas at El Paso, Rehabilitation Sciences Complex
Start Date
2025-10-15
Trial ID
NCT07211412
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested